1821666-74-3

2,3-Dimethyl-6-(methyl(2-((4-methyl-3-sulfamoylphenyl)amino)pyrimidin-4-yl)amino)-2H-indazole 2-oxide is an impurity of Pazopanib (P210925) which is an oral angiogenesis inhibitor targeting VEGFR and PDGFR.